AI Revolution in Healthcare Gains Momentum as FDA Prepares for Tech Boom

USA News Group Commentary
Issued on behalf of Avant Technologies Inc.

VANCOUVER, BC, Sept. 24, 2024 /PRNewswire/ -- USA News Group – Health care is undergoing a tech revolution, with health systems increasingly leveraging artificial intelligence (AI) bots for primary care. Even the US FDA has initiated a consolidation of its AI-related activities under a single AI Council, to better prepare for the wave of AI-powered innovations in the space. Analysts at Precedence Research see massive growth of AI in healthcare, projecting a 36.83% CAGR through to a US$613.81 billion by 2034. Several innovative tech companies are moving ahead with development in the space, Working behind the scenes are several AI and biotech developers looking to improve the potential for AI in healthcare, including Avant Technologies Inc. (OTCQB: AVAI), Butterfly Network Inc. (NYSE: BLFY), GE HealthCare Technologies Inc. (NASDAQ: GEHC), Exscientia plc (NASDAQ: EXAI), and Recursion Pharmaceuticals Inc. (NASDAQ: RXRX).